Dr. Dora Hammerl
VP R&D, Co-Founder
Dora co-founded Pan Cancer T with Prof. Reno Debets in 2020. She brings 8 years of international experience in Immuno-oncology research. Prior to Pan Cancer T, Dora studied T cell evasive mechanisms in solid cancer as a Research Fellow at the Department of Medical Oncology (Erasmus MC fellowship and NWO Veni). She worked for 18 months at La Jolla Institute, San Diego, CA, in the field of tumor Immunology and then joined the Debets Laboratory at Erasmus MC, where she obtained her PhD in T cell immunity and TCR therapy for breast cancer. Dora has a background in Molecular Biology from the University of Vienna and received her MSc in Biopharmaceutical Sciences from Leiden University.
